Clinical Trials in Arizona

Showing 1701-1720 of 14,395 trials

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy

NCT06055881

This study assesses if metastasis-directed radiation therapy (Stereotactic body radiation therapy - SBRT) can delay a change in systemic therapy, and if circulating tumor cells in the bloodstream can help guide treatment options in metastatic breast cancer patients with progressive disease

Breast CarcinomaAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Cancer

Mayo Clinic45 participantsStarted Oct 2023

Scottsdale, Arizona, United States • Rochester, Minnesota, United States

COMPLETEDPhase 331 miles

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

NCT00066690

RATIONALE: Estrogen can stimulate the growth of breast tumor cells. Ovarian function suppression combined with hormone therapy using tamoxifen or exemestane may fight breast cancer by reducing the production of estrogen. It is not yet known whether suppression of ovarian function plus either tamoxifen or exemestane is more effective than tamoxifen alone in preventing the recurrence of hormone-responsive breast cancer. PURPOSE: This randomized phase III trial studies ovarian suppression with either tamoxifen or exemestane to see how well they work compared to tamoxifen alone in treating premenopausal women who have undergone surgery for hormone-responsive breast cancer.

Estrogen Receptor Positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast Carcinoma+5 more

ETOP IBCSG Partners Foundation3,066 participantsStarted Dec 2003

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Scottsdale, Arizona, United States +497 more locations

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Find Trials by Condition in Arizona

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

Randomized Study of the pdSTIM™ System in Failure to Wean Mechanically Ventilated Patients

A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users

ICG Fluorescence Imaging in Post-traumatic Infection

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition

Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study

PrEP Affect Regulation Treatment Innovation

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1